Two novel mutations in ADAMTS13 in a Chinese boy with congenital thrombocytopenic purpura: a case report
Abstract Background Mutations in the ADAMTS13 gene family have been reported to cause congenital thrombotic thrombocytopenic purpura (cTTP), a rare disease characterized by thrombocytopenia and hemolytic anemia. Nearly 150 causative mutations in ADAMTS13 have been identified; however, only a few of...
| Published in: | BMC Medical Genetics |
|---|---|
| Main Authors: | Ling Hou, Yue Du |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2020-03-01
|
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s12881-020-00996-1 |
Similar Items
Immune thrombotic thrombocytopenic purpura: Personalized therapy using ADAMTS‐13 activity and autoantibodies
by: Francesca Palandri, et al.
Published: (2021-12-01)
by: Francesca Palandri, et al.
Published: (2021-12-01)
Prophylactic use of recombinant ADAMTS-13 during pregnancy for congenital thrombotic thrombocytopenic purpura
by: Éloïse Colliou, et al.
Published: (2025-01-01)
by: Éloïse Colliou, et al.
Published: (2025-01-01)
Anti-ADAMTS13 Autoantibodies in Immune-Mediated Thrombotic Thrombocytopenic Purpura
by: Michael R. Snyder, et al.
Published: (2025-03-01)
by: Michael R. Snyder, et al.
Published: (2025-03-01)
Inherited ADAMTS13 mutations associated with Thrombotic Thrombocytopenic Purpura: a short review and update
by: Zoe Markham-Lee, et al.
Published: (2023-01-01)
by: Zoe Markham-Lee, et al.
Published: (2023-01-01)
Hereditary thrombotic thrombocytopenic purpura and COVID‐19: Impacts of vaccination and infection in this rare disease
by: Erika Tarasco, et al.
Published: (2022-10-01)
by: Erika Tarasco, et al.
Published: (2022-10-01)
Novel ADAMTS13 mutations in a patient with congenital thrombotic thrombocytopenic purpura
by: Zhitao Wang, et al.
Published: (2023-12-01)
by: Zhitao Wang, et al.
Published: (2023-12-01)
Anti-ADAMTS13 Antibodies and a Novel Heterozygous p.R1177Q Mutation in a Case of Pregnancy-Onset Immune-Mediated Thrombotic Thrombocytopenic Purpura
by: Elien Roose, et al.
Published: (2018-01-01)
by: Elien Roose, et al.
Published: (2018-01-01)
Congenital Thrombotic Thrombocytopenic Purpura: Atypical Presentation And First ADAMTS 13 Mutation In A Tunisian Child
by: aida borgi
Published: (2013-06-01)
by: aida borgi
Published: (2013-06-01)
Relapse of Immune Thrombotic Thrombocytopenic Purpura Following Vaccination with COVID19 mRNA Vaccine
by: Katerina Pavenski
Published: (2021-07-01)
by: Katerina Pavenski
Published: (2021-07-01)
Rituximab for acute plasma-refractory thrombotic thrombocytopenic purpura - a case report and concise review of the literature
by: D Brodmann
Published: (2007-09-01)
by: D Brodmann
Published: (2007-09-01)
Atypical Presentation of Thrombotic Thrombocytopenic Purpura without Hematological Features
by: Balraj Singh, et al.
Published: (2020-07-01)
by: Balraj Singh, et al.
Published: (2020-07-01)
Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura
by: Mari R. Thomas, et al.
Published: (2015-08-01)
by: Mari R. Thomas, et al.
Published: (2015-08-01)
A compound heterozygous ADAMTS13 mutation causes congenital thrombotic thrombocytopenic purpura: a case report
by: Yezi Huang, et al.
Published: (2025-01-01)
by: Yezi Huang, et al.
Published: (2025-01-01)
Post-cardiac surgery thrombotic thrombocytopenic purpura: presence of anti-ADAMTS13 autoantibodies at preoperative baseline
by: Bryan Tordon, et al.
Published: (2022-04-01)
by: Bryan Tordon, et al.
Published: (2022-04-01)
Mechanistic insight into multiple antibody binding to ADAMTS13 in immune thrombotic thrombocytopenic purpura
by: Konstantine Halkidis, et al.
Published: (2024-10-01)
by: Konstantine Halkidis, et al.
Published: (2024-10-01)
The economic and social burden of congenital thrombotic thrombocytopenic purpura (cTTP) in Italy
by: Filippo Rumi, et al.
Published: (2024-10-01)
by: Filippo Rumi, et al.
Published: (2024-10-01)
Quantitative Systems Pharmacology Modeling of Platelet Responses to Recombinant ADAMTS13 in Patients With Congenital Thrombotic Thrombocytopenic Purpura
by: Cameron McBride, et al.
Published: (2025-10-01)
by: Cameron McBride, et al.
Published: (2025-10-01)
Clinical presentation and treatment of thrombotic thrombocytopenic purpura - analysis of recent diagnostic and therapeutic methods
by: Jan Szwech, et al.
Published: (2025-03-01)
by: Jan Szwech, et al.
Published: (2025-03-01)
Frontline use of rituximab may prevent ADAMTS13 inhibitor boosting during caplacizumab treatment in patients with iTTP: post hoc analysis of a phase 2/3 study in Japan
by: Kazunori Imada, et al.
Published: (2024-08-01)
by: Kazunori Imada, et al.
Published: (2024-08-01)
Idiopathic Relapsing Thrombotic Thrombocytopenic Purpura with Persistent ADAMTS13 Inhibitor Activity Treated Sequentially with Plasmapheresis, Rituximab, Cyclophosphamide and Splenectomy
by: Faisal Musa, et al.
Published: (2015-04-01)
by: Faisal Musa, et al.
Published: (2015-04-01)
Thrombotic thrombocytopenic purpura as a rare cause of anemia with thrombocytopenia in childhood: report of 2 cases
by: Oya Köker, et al.
Published: (2019-06-01)
by: Oya Köker, et al.
Published: (2019-06-01)
Economic impact of a rapid, on‐demand ADAMTS‐13 activity assay for the diagnosis of thrombotic thrombocytopenic purpura
by: Alicia White, et al.
Published: (2022-05-01)
by: Alicia White, et al.
Published: (2022-05-01)
Clinical observation of a patient with thrombotic thrombocytopenic purpura with renal and intestinal lesions
by: A G Stolyar, et al.
Published: (2019-07-01)
by: A G Stolyar, et al.
Published: (2019-07-01)
Inherited thrombotic thrombocytopenic purpura mimicking immune thrombocytopenic purpura during pregnancy: a case report
by: Valter Romão de Souza, et al.
Published: (2018-01-01)
by: Valter Romão de Souza, et al.
Published: (2018-01-01)
Generation and validation of small ADAMTS13 fragments for epitope mapping of anti‐ADAMTS13 autoantibodies in immune‐mediated thrombotic thrombocytopenic purpura
by: Kadri Kangro, et al.
Published: (2020-07-01)
by: Kadri Kangro, et al.
Published: (2020-07-01)
Diagnosis of thrombotic thrombocytopenic purpura
by: G. M. Galstyan, et al.
Published: (2020-12-01)
by: G. M. Galstyan, et al.
Published: (2020-12-01)
Caplacizumab in the Treatment of Patients with Recurrent Thrombotic Thrombocytopenic Purpura (TTP)
by: Mihaela-Sabrina HERDEA, et al.
Published: (2025-03-01)
by: Mihaela-Sabrina HERDEA, et al.
Published: (2025-03-01)
Evaluation of the Plasmic Score for the Prediction of Adamts13 Activity in Patients with Thrombotic Microangiopathies
by: Giovanni Tiscia, et al.
Published: (2018-07-01)
by: Giovanni Tiscia, et al.
Published: (2018-07-01)
Diagnosis and follow‐up of thrombotic thrombocytopenic purpura with an automated chemiluminescent ADAMTS13 activity immunoassay
by: Nicolas Beranger, et al.
Published: (2021-01-01)
by: Nicolas Beranger, et al.
Published: (2021-01-01)
A rare case of hereditary thrombotic thrombocytopenic purpura in a toddler
by: Ozana Jakšić, et al.
Published: (2023-01-01)
by: Ozana Jakšić, et al.
Published: (2023-01-01)
Recurrent stroke in an African female with idiopathic thrombotic thrombocytopenic purpura: A case report
by: Kwabena Oteng Agyapong, et al.
Published: (2023-01-01)
by: Kwabena Oteng Agyapong, et al.
Published: (2023-01-01)
Emergency Plasmapheresis in a case of ThromboticThrombocytopenic Purpura (TTP)
by: Mariaserena Pioli Di Marco, et al.
Published: (2013-12-01)
by: Mariaserena Pioli Di Marco, et al.
Published: (2013-12-01)
The Progress in Research in Hereditary Thrombotic Thrombocytopenic Purpura in Children
by: FU Lingling, et al.
Published: (2022-10-01)
by: FU Lingling, et al.
Published: (2022-10-01)
EB virus reactivation triggers thrombotic thrombocytopenic purpura in a healthy adult
by: Satoko Oka, et al.
Published: (2017-01-01)
by: Satoko Oka, et al.
Published: (2017-01-01)
Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpura
by: Elverdi T, et al.
Published: (2019-04-01)
by: Elverdi T, et al.
Published: (2019-04-01)
گزارش یک مورد درمان موفقیتآمیز Thrombotic Thrombocytopenic Purpura در حاملگی
by: Maliheh Amiriam, et al.
Published: (2016-08-01)
by: Maliheh Amiriam, et al.
Published: (2016-08-01)
Outcome of Thrombotic Thrombocytopenic Purpura Patients: A Single-Center Experience
by: Özcan Çeneli, et al.
Published: (2019-08-01)
by: Özcan Çeneli, et al.
Published: (2019-08-01)
A comparative study of anti–ADAMTS-13 antibody dynamics in immune-mediated thrombotic thrombocytopenic purpura
by: Maria Rita Cozzi, et al.
Published: (2024-07-01)
by: Maria Rita Cozzi, et al.
Published: (2024-07-01)
Immune thrombotic thrombocytopenic purpura: Spotlight on long-term outcomes and survivorship
by: Sruthi Selvakumar, et al.
Published: (2023-02-01)
by: Sruthi Selvakumar, et al.
Published: (2023-02-01)
Hereditary thrombotic thrombocytopenic purpura mimicking immune thrombocytopenia was revealed by miscarriage—novel compound heterozygous mutations in hTTP
by: Ruiqing Zhou, et al.
Published: (2024-11-01)
by: Ruiqing Zhou, et al.
Published: (2024-11-01)
Similar Items
-
Immune thrombotic thrombocytopenic purpura: Personalized therapy using ADAMTS‐13 activity and autoantibodies
by: Francesca Palandri, et al.
Published: (2021-12-01) -
Prophylactic use of recombinant ADAMTS-13 during pregnancy for congenital thrombotic thrombocytopenic purpura
by: Éloïse Colliou, et al.
Published: (2025-01-01) -
Anti-ADAMTS13 Autoantibodies in Immune-Mediated Thrombotic Thrombocytopenic Purpura
by: Michael R. Snyder, et al.
Published: (2025-03-01) -
Inherited ADAMTS13 mutations associated with Thrombotic Thrombocytopenic Purpura: a short review and update
by: Zoe Markham-Lee, et al.
Published: (2023-01-01) -
Hereditary thrombotic thrombocytopenic purpura and COVID‐19: Impacts of vaccination and infection in this rare disease
by: Erika Tarasco, et al.
Published: (2022-10-01)
